Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.67B
Enterprise Value3.68B
P/E Ratio47.54
PEG Ratio-5.23
Price/Sales Ratio3.5
Price/Book Ratio1.65
Enterprise/Revenue3.8
Enterprise/EBITDA17.92

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue745.31M
Revenue/Share1.43
Gross Profit174.07M
EBITDA163.19M
Net Income54.34M
Diluted EPS0.09

Balance Sheet

Total Cash360.81M
Total Cash/Share0.62
Total Debt609.2M
Total Debt/Equity0.35
Current Ratio4.08
Book Value Per Share2.99

Price History

52-Week Change-16.58
52-Week High6.82
52-Week Low4.46
Moving Average 50 Days5.1
Moving Average 200 Days5.32

Statistics

Average Volume8.99M
Shares Outstanding593.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.01
Trailing Annual Dividend Yield0.24
Payout Ratio0.21
Last Split Factor2:1
Last Split DateMay 31, 2016
AD